Persistent Headache Following COVID-19: Clinical Trials

1 trial for Persistent Headache Following COVID-19, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1

Follow Persistent Headache Following COVID-19: new trials by email Literature Review of Persistent Headache Following COVID-19 trials Research Report on Persistent Headache Following COVID-19

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effect of Ganglion Sphenopalatine Block Versus Placebo on Persistent Headache Following COVID-19 Infection
Sphenopalatine Ganglion Block with Local Anesthetic, Sphenopalatine Ganglion Block with Placebo (Isotone NaCl), "Sham"-block with Placebo (Isotone NaCl) - Headache, Covid19
Phase 3TerminatedUniversity Hospital Bispebjerg and Frederiksberg182021-01-122022-06-10

Narrower conditions

COVID-19 (1)  ·  Headache (1)

Broader conditions

Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Neurologic Manifestations (1)  ·  Nidovirales Infections (1)  ·  Pain (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Pneumonia (1)  ·  Pneumonia, Viral (1)  ·  RNA Virus Infections (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)  ·  Signs and Symptoms (1)  ·  Virus Diseases (1)

Interventions

Anesthetics, Local (1)  ·  Sphenopalatine Ganglion Block (1)

Sponsors

University Hospital Bispebjerg and Frederiksberg (1)

Countries

Denmark (1)

Top investigators

Christian S Meyhoff, PhD (1)